Share Name Share Symbol Market Type Share ISIN Share Description
Cello Health Plc LSE:CLL London Ordinary Share GB00B0310763 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 125.50p 124.00p 127.00p 125.50p 125.50p 125.50p 14,903 07:45:19
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Media 165.6 8.4 6.3 20.0 132

Cello Health PLC Block listing Interim Review

24/05/2019 12:45pm

UK Regulatory (RNS & others)

Cello Health (LSE:CLL)
Historical Stock Chart

2 Months : From May 2019 to Jul 2019

Click Here for more Cello Health Charts.


RNS Number : 1647A

Cello Health PLC

24 May 2019

24 May 2019

Cello Health plc

("Cello" or the "Company")

Additional Block Listing of Ordinary Shares

Block Listing Update

The Company announces that an application has been made to the London Stock Exchange for a block admission for 2,368,200 new ordinary shares of 10p each ("Ordinary Shares") to be admitted to trading on AIM.

These new Ordinary Shares will be issued and allotted from time to time pursuant to the exercise of existing options under the Company's PSP Option Scheme 2010, its Approved Share Option Plan 2009 and its Unapproved Scheme 2010. The new Ordinary Shares, when issued, will rank pari passu with the existing Ordinary Shares of the Company. Admission of the new Ordinary Shares is expected to occur on 31 May 2019.

Further to the announcement by the Company on 14 December 2018, the Company also announces that a total of 61,061 new ordinary shares of 10p each in the share capital of the Company have been issued and allotted since that date (pursuant to the Company's PSP Option Scheme 2010, its Approved Share Option Plan 2009 and its Unapproved Scheme 2010) and admitted to trading in accordance with the block listing applied for at that time (the "Block Listing"). An update in accordance with Schedule 6 of the AIM Rules for Companies is set out below.


 Cello Health                   020 7812 8460 
 Mark Scott, Chief Executive 
 Mark Bentley, Group Finance 
 Cenkos Securities              020 7397 8900 
 Mark Connelly 
 Harry Hargreaves 
 Buchanan                       020 7466 5000 
 Mark Court 
 Jamie Hooper 
 Sophie Wills 


 Name of applicant:                        Cello Health plc 
 Name of scheme:                           PSP Option Scheme 2010, Approved 
                                            Share Option Plan 2009 and Unapproved 
                                            Scheme 2010 
 Period of return:               From:     31 November       To:    23 May 2019 
                                --------  ----------------  -----  ------------------ 
 Balance of unallotted securities 
  under scheme(s) from previous 
  return:                                  611,608 
 Plus: The amount by which the 
  block scheme(s) has been increased 
  since the date of the last 
  return (if any increase has 
  been applied for):                       2,368,200 
 Less: Number of securities 
  issued/allotted under scheme(s) 
  during period (see LR3.5.7G):            (61,061) 
 Equals: Balance under scheme(s) 
  not yet issued/allotted at 
  end of period:                           2,918,747 
 Name of contact:                          Mark Bentley, Group Finance Director 
 Telephone number of contact:              020 7812 8460 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit



(END) Dow Jones Newswires

May 24, 2019 07:45 ET (11:45 GMT)

1 Year Cello Health Chart

1 Year Cello Health Chart

1 Month Cello Health Chart

1 Month Cello Health Chart
Your Recent History
Cello Heal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20190722 18:09:28